ArticleAlzheimer's research & therapy2023

Convergent transcriptomic and genomic evidence supporting a dysregulation of CXCL16 and CCL5 in Alzheimer's disease.

Xiao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.